Interim report
Page 1
November 3, 2026 To, BSE Limited, 25, P. J. Towers, Dalal Street, Mumbai – 400 001 Ref: Company Scrip Code: 532834 To, Listing Department, National Stock Exchange of India Ltd., Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400051 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Outcome of the Board Meeting: Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”) (read with Schedule III). Dear Sir/Madam, This has reference to our intimation dated October 29, 2026. In this regards, we wish to inform you that the Board of Directors, at its meeting held today i.e. on Tuesday, November 3, 2026, inter alia, approved and noted the following: 1. Un-audited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee. A copy of the said Results along with the Limited Review Reports issued by the Statutory Auditors are enclosed herewith as Annexure 1. The said Results shall be published in newspapers as per the SEBI Listing Regulations. 2. Raising of fund by way of issue of equity shares of the Company of face value ₹ 1 each through Rights Issue for an amount not exceeding ₹ 250 crores to the eligible equity shareholders of the Company as on the record date (to be determined by the ‘Securities Issue and Allotment Committee’ of the Board and notified subsequently) subject to receipt of statutory / regulatory approvals, as may be applicable in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosures Requirements) Regulations, 2018 and other applicable laws. For the purposes of giving effect to the rights issue, the detailed terms to the rights issue including but not limited to issue price, rights entitlement ratio, record date, timing and terms of payment will be determined subsequently by the Board, or the ‘Securities Issue and Allotment Committee’ constituted by the Board, in accordance with applicable laws, subject to receipt of necessary approvals, as may be required. 3. The administrative warning letter bearing reference no. I/24675/2026 dated October 29, 2026 issued by SEBI for violation of provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure relating to the rights issue, as required pursuant to Regulation 30 of SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is attached herewith as Annexure 2. The above information is also available on the Company’s Website at (https://www.camlinfs.com/). The Board meeting commenced at 02:00 p.m. (IST) and concluded at 03:35 p.m. (IST).
Page 2
This is for your information and record please. Thanking You, For Camlin Fine Sciences Limited Rahul Sawale Company Secretary & VP ‐ Legal Encl.: a/a.
Page 3
4 + ~ N N CJ) '..J 0 0 ~ 0 0 0 11 + ~ N N N OJ (N N ~ ~ 0 ~ a n 0 ..... Ll 0 ..... Q) rt <D @ n Q) 3 ::J ...,., (/1 n 0 3 (] ::E ::E ~ n Q) 3 ::J ...,., !I' n 0 3 -0 () () :0 - Q) <D ~ 3 If!. r =: "' '..J ::J ; ~ Tl .... ~ -· ID 0 ::J a. 0 <D 0 3: Ul -I Q. :::!? ~ <D n (!) ::J <D l.!l n . . (N <D IJ (/1 rr () - · o3 '..J;:::;: (.11 <D VJ Q. CJ) - ~ Tl 0 0 ..... N rt 0 Y1 ::J G) (n IJ 0 ::J .rt () Ul -l ;u 0 Q) p.. ~ Q) ::J _ai Ul Q) ::J rt Q) n ..... c N ,..., rn Q) (/1 rt ::-' 3: c 3 0- Q) ~ 0 0 0 (!) ~ CAMLIN FINESCil·NCFS l.l~llTED STATEMENT OF UNAUOl lED FIJ'\ANClAL RESULTS FOll I llF QUAllTFR A '\D HALF Yb\R FNDrD SFl'1 EMBl'll30, 2026 STANDALONE QUAR fEll FNDFD llALF YEAR ENDED PARTICULARS 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) 1 Revenue> from opera tions 2.445.83 2,224.86 2,440.42 4,670.68 4,35-1.80 2 Other income 45.36 t4.02 tOl .94 50.18 138.82 3 Total Incomc 2,491.19 2,238.88 2,542.36 4,720.86 4,493.62 4 Expenses Cos t o( materials consu med 1,634.44 1,455.98 1,144.01 3,090.42 2,134.62 Purchase of stock in trade 37.49 14.88 3.71 52.38 8.42 Cha nges m irl\'cntorics of finished goods/\VIP/stod. m trade 10.56 (141.35) 193.65 (130.79) 223.15 Employee bE>ncfits C'\pense 204.22 202.78 193.56 407.00 379.76 Finance cos ts 154.87 133.82 187.29 288.69 300.73 Dcprcuat1on and amor tisation ex pens e 137.92 135.12 134.74 273.04 268.77 Other C'"<p<'n'iC'S 623.43 624.37 723.49 1,238.60 1,380.03 Total E).penS<'S 2,80293 2,425.60 2,580.46 5,219.34 4,695.48 5 Profit/ (I ass) before exceptional items and shar(' of profit/ (311.74) (186.721 (38.10) (498.48) (201.86) (loss) of associate (3-4) 6 Excf'ptional itrm s (Refer Note 5) 7 Profit/ (I oS<j hofore share of profit/ (loss) of aS<ociato (S-61 (311.74) (186.72) (38.10) (498.48) (201.86) 8 Share of profit / ( loss) of associa te 9 Profit / (Loss) before tax from continuing opcraliono; (7-8) (311.74) (186.72) (38.10) (498.48) (201.86) 10 Tdx ExpcnSC'S -Current la\ - - Deferred t<tx (111.65) (63.60) (1.7 1) (175.24) (58.67) Total lax ExpC'n.!tCS (111.65) (63.60J (1 .71) (175.24) (58.67) 11 Profit / (I oss) fro m continuing operations for th e pC'riod (9-10) (200.09) (123.12) (36.39) (323 .24) (143.19) 12 Dis continul 1d opt.•rations (Refer Note 6) Profit/ (Loss) f1orn discon tinued operation before' Id\ Lt\ expense' of dtslon tinued operations Profit/ (Loss) from discontinued operations - 13 Profit/ (! oss) for tho period (11+12) 1200.09) 1123.12 {36.39 {323.24 1143.191 H Other lOmprehensivc income A rtem s thJt will not be reclassified to profit or loss (i) Remeasurements of d<:'fin<:'d benefit plans 2.31 (0 70) (1 1.67) 1.61 (10.11) (ii) InconH' la' r<:'l.1tmg to Hems that w ill nol be rcclass1fiC'd to profit (0.81) U.24 4.08 (0.56) 3.53 or loss B lt ems that will he> rC'CIJ.,~iCied to profit or l oss (1) Fxch.rngc diffcrencC's on translatin g the fin?ncial slttll"ments of foreign operations (1i} rhe effect1v<:' portion of gain or loss on hedging in£lrum{"nts 21.54 57.B (53.7 1) 78.88 (51.81) tn a cash now hedge (11 i) Income tax relatmg to Items that will be reclassified to 1•roht (7.53) (20.03) 18.77 (27.56) 18.10 or loss Other compreh ensive income 15.51 36.84 (42.53) 52.:l7 (40.29) 15 Total compr('h cnsivc in(o mc for the period (13+14) ,,...,_,, "- .. 186.28 (78.92 {270.87 (183.48) ,0,~C ,_«;-;:;;, - ) (Rs.in Million, except per share data) CONSOLIDATED YEAR QUAllTER ENDED HALF YEAR ENDED YEAR ENDED ENDED 31.03.2026 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09 .2025 31.03.2026 (Audited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 8,379.18 4,914.65 5,198.79 4,502.65 10,113.44 8,579.86 17,233.08 349.5 1 49.56 13.40 42.62 27.03 108.89 287.92 8,728.69 4,964.21 5,212.19 4,545.27 10,140.47 8,688.75 17,521.00 4,018.22 2,641.98 3,123.48 2,090.23 5,765 .46 4,348.77 8,232.70 36.91 293.16 58.20 352.63 351.36 551.58 886.01 404.05 21.77 (124.85) (31.80) (103.08) (232.44) 105.75 759.80 722.66 734.29 594.69 1,456.95 1,162.11 2,439.01 669.87 205.92 140.05 178.48 345 .97 327.()4 729.40 536.77 199.19 191.56 176.55 390.75 337.88 709.19 2,681.31 1,212.75 1,314.92 1,140.62 2,491.75 2,190.63 4,500.82 9,106.92 5,297.43 5,437.65 4,501.40 10,699.16 8,685.57 17,602.88 (378.23) (333.22) (225.46) 43.87 (558.69) 3.18 (81.88) 162.70 19.26 111.10 130.36 254.60 (540.92) (352.48) (336.56) 43.87 (689.05) 3.18 (336.48) 3.61 13.97 (3.58) 17.58 5.33 16.62 (540.92) (348.87) (322.59) 40.29 (671.47) 8.51 (319.86) 44.89 38.57 56.11 83.46 115.87 179.21 (211.26) (112.95) (43.20) 2.84 (156.14) (57.17) (183.76) (211 .26) (68.06) (4.63) 58.95 (72.68) 58.70 (4.55) (329 .66) (280.81) (317.96) (18.66) (598.79) (50.19) (315.31) (16.19) (18.26) (130.84) (34.45) (205.80) 552.42 0.32 1.68 (16.19) (18.26) (130.84) (34.45) (206.12) 550.74 1329.661 {297.00) 1336.221 1149.50) 1633.241 {256.31 235.43 (l.61) 2.31 (0.70) (11.67) 1.61 ( 10.11) (1.24) 0.56 (0.81) 0.24 4.08 (0.56) 3.53 0.56 (65.16) 135.76 32.75 70.60 149.79 80.96 (70.57) 21.54 57.'\3 (53.7 1) 78.88 (51.81) (70.57) 24.66 (7.53) (20.03) 18.77 (27.56) 18.10 24.66 ~ ~0. 2 l1 (46.96) (49.65) 172.60 (9.78) 122.97 109.50 34.37 l376.62i l346.65' l163.62l 1159.28) 1510.271 1146.81 269.80 ~SJ ~ ~~ = co .- ,.....-lt-~ ... m=
Page 4
<;. <> () () ::0 + - OJ (!) ~ !2:'. 3 ce. N r ::: VI N '-J ::::i CD' .!'>..,, .... (j) __,l -· CD '-J 0 ::J a. 0 0 <D 0 3: (/) 0 I £2. 3; 0 ~ ro n 0 (.() ::J !I! 0 (.() (') v.i <D lJ (/l rr () -· o3 111 '-J ;:::;: Ul ro v.i Q_ (j) - + ~..,, ~ 0 0 N .... N N N ,..,. 00 0 w _Ul N .!'> :J .j:>. 0 G> .j:>. (n lJ 0 ::J D _,..,. () (/) --l (') ;u 0 .... 0 'O OJ 0 P-.... OJ /\ ,..,. ro OJ @ ::J (') _OJ OJ 3 (/) OJ ::J ::J ...., ,..,. !" OJ (') (') .... 0 c 3 N ,,..., m OJ (/l ,..,. (] ~ 3: c 3 O" OJ .j:>. 0 STANDALONE CONSOLIDATED QUAHTER ENDED HALF YEAH ENDED YEAR ENDED QUARTER ENDED IlALFYEAR ENDED YEAR ENDED PARTICULARS 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 30.09.2026 30.06.2026 30.09.2025 30 .09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudited) (Unaudi ted) (Unaudi ted) (Audited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaud ited) (Audited) 16 Profit/ (Loss) attributable to: {i) Owners or the Company (278.54) (317.06) (143.84) (595.62) (243.45) 276.27 (ii) ;..,'on·controlling interests (18.46) (19.16) (5.66) (37.62) (12.86) (40.84) Profit attributable to owners arises from: Continuing operations (267.35) (309.02) (17.14) (576.39) (46.72) (300.81) Discontinued operations (11.19) (8.04) (126.70) (19.23) (196.73) 577.08 17 Other comprehensive income attributablP to: (i) Owners of the Com pany (39.76) 177.48 (1.15) 137.74 117.91 71.11 (ii) :'\on-controlling interests (9.89) (4.88) (8.63) {14.77) (8.41) (36.74) 18 Total comprehensive income attributable to: (i) Owners of the Co mpany (318.30) (139.58) (144.99) (457.88) (125.54) 347.38 (ii) >:on-controlling interests (28.35) (24.04) (14.29) (52.39) (21.28) (77.58) Total comprehensive income attributable to owners arises Continu ing operations (307.11) (131.54) (18.29) (438.65) 71.20 (229.70) Discontinued operations (11.19) (8.04) (126.70) (19.23) (196.73) 577.08 19 Pd id-up Equity Share Cap ital (Face Valur Rs.1 /-pe r sha re) 192.10 192.IO 187.98 192.10 187.98 192.09 192.10 192.10 187.98 192.10 187.98 192.09 20 Other Equity 8,847.42 8,255.77 9,0%.16 9,528.63 8,707.75 10,216.7'1 EMnings per Share (EPS) for profit from continuing operation (of l<c I /-c,teh) (not annualised) B•SJC (Rs.) (1.39) (1.60) (0.09) (3.00) (0.25) (1.59) Diluted (Rs.) (1.39) (1.60) (0.09) (3.00) (0.25) (1.59) Earnings per Share (EPS) for profit from discontinued operation (of Re I /-Pac h) (no t annualised) Basic (Rs.) (0.06) (0.05) (0.67) (0.10) {l.05) 3.05 Diluted (Rs.) (0.06) (0.05) (0.67) (0.10) {l.05) 3.01 2t bunings per Share (EPS) for profit from continuing and discontinued operation (of Re 1/-each) (not annualised) Basic (Rs.) (1.04) (0.64) (0.19) (1.68) (0.76) (1.74) (1.45) (1.65) (0.77) (3.10) (1.30) 1.46 Diluted (Rs.) (1.04) (0.64) (0.19) (1.68) (0.76) (1.74) (1.45) (1.65) (0.77) (3.10) (1.30) 1.44 Notes to Standalone and Consolidated Unaudited Financial Results: 1 The above results which are published in c:tccordanr<' with Regulation 33 of the SEHi (Listing Obligations & Disclosure Requirements) Regu lations, 2015, as amended, have been reviewed by the Audit Co mmittee and approved by the Board o( Directors at their respective meetings held on >Jovcmber 03, 2026. The financial r<'!ioults have been prepared in accordance with the recognition and measur ement principles laid down in the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read wilh relevant rules issued thcrC'under, and other accounting principles generally accepted in India . 2 Other income / Other expense above relating to .... ontin uing operations includes net foreign exchange gain/ (loss) for each reporting penod as under: ,---- - ------- STANDALONE CONSOLIDATED QUAHTl ·R ENDED llALFYl 'AR ENDED YEAR QUARTER ENDED IlALF YEAR ENDED YEAR Particulars ENDED ENDED 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 30.09.2026 30.06.202 6 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (U naudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) (Unaudi ted) (Unaudited) (Unaudited) (Unaudit ed) (Audited) Exchange gain 31.94 74.48 22.74 80.59 239.92 35.93 28.68 90.12 189.51 Exchange loss 9.20 83.69 47.76 Total Exchanl',e Gain/ (Loss) 31.94 (9.20) 74.48 22.74 80.59 239.92 35.93 (83.69) 28.68 (47.76 90.12 189.51 -~/ (loss) shown above excludes exchange gain/ (loss) on dcrivati\'e con tracts accounted as cash flow hedge. 0. Cl ~~ ~= (!) ..... ~--rn t:S
Page 5
4 ~ () () ::0 + - Q) (!) ~ ~ 3 ce. N r =:VI N '-I :J it (J) .i::. ,, ... --" -· ti> '-I 0 :J a. 0 Q<I> 0 3: (/') 0 ~ I 0. :!; 0 ~ <D 0 0 <.O :J !!! 0 <.O () w <D "CJ IJ1 rr () -· o3 ~· '-I;::;: (Jl <D w 0.. (J) - + ~ ,, ~ 0 0 N ... N N N ...... CX> 0 w _(Jl N .i::. :;- ~ 0 0 ~ ~ "CJ Q. :J a _ ...... () (/') -l () ::0 0 .., 0 -0 Q) 0 0.. .., - QJ ~ ...... <D Q) @ :J () _O> QJ 3 (/') Q) :J :J ...., ...... Vl Q) ri () ... 0 c 3 N ,,..... rn Q) IJ1 ...... ~ 3: c 3 ~ 0- ~ QJ ~ ~ ri 0 QJ 0 3 0 <.O :J ...., ~ Vl ri 0 3 3 Finance costs of continuing operation include foreign exchange gain/ (loss) for each rcportmg period as under: (Rs.in Million) STANDALONE CONSOLIDATE D QUARTER ENDED HALF YEAR ENDED YEAR ENDED QUARTER ENDED HALF YEAR ENDED YEAR ENDED Parti culars 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Una udit ed) (U naudit ed) (Unaudited) (Audited) (Unaudited) (Una udited) (Unaudited) (Una udit ed) (Unaudi ted) (Audi ted) Exchan~e r.ain 1.83 22.73 Exchange loss 24.15 66.65 22.32 65.62 174.27 37.21 37.03 14.49 46.28 82.39 Total Exch•nge Gain/ (Loss) (24.15) 1.83 (66.65) (22.32) (65.62) (174.27) (37.21) 22.73 (37.03) (14.49 (46.28) (82.39) 4 D uring the cu rrent quarter, the Company has neither issued nor ctllotted employee stock options under any of the Employees Stock Option Plans (ESOP). 39,000 employee stock options have lapsed under ESOP-2021 which have been added back to the op tion pool and are eligible for re-issue . 5 On June 23, 2026, the Company launched an open offer to acquire up to 738,099 equity shares held by minority shareholde rs of Vinpai S.A. ("Vmpa1") at a pnce o( Euro 3.60 per share (face value o( Euro 0.10 per share and securities premium of Euro 3.50 per share). The ope n offer closed on July 6, 2026, pursu~rnt to which 501,842 equity shares were tendered and acqu ired for consideration o( r;-.:R 200.90 million. Consequen tly, the Company's shareho lding in Vinpai increased to 4,325,158 equity shares (excluding 26,736 treasury shares) , rcp resenttn g 94.82°' of Vmpa1 share ca pital . ln acco rdance with Ind AS 110, the acquisition of the additional eqUlty interest has been accounted for as an equity transac tion and hence the consideration patd and the negative carry ing value of the net assets attributabl e to the acquired non co nlrollin g interest of I:'\~ 49.75 million, amounting to rNR 250.65 million has been recognized m Other Equity. Further, the Compdny incurred expenses of L'JR 19.26 million reldting to the open offer has been disclosed under exceptional item. 6 Loss from 'Dbco ntinu ed Operations-Expenditure of Rs.16.19 ~l11!1on relating to the discontinued operations of subsidiary, CFS Wanglong Flavours (Ningbo) Co. Ltd. 7 During the current quarte r, Company has incurred expenses o( l>JR 50.64 million in respect of the Di phenol plant at DaheJ. The plant rem dined under shutdown during the quarter owing to prevai.hng geopolitical uncertain ties and advers<' eco nomic conditio ns. 8 As per the requirements oflnd AS·l 08 on "Ope rating Segment ", Consolida tl'Ci segment wise information has been provided in Annexure -1. Place: Mumbai Date: Novembe r 03, 2026 For Cam lin Fine Sciences Limited ~ Ash1sh S. Dandekar Chairma n & Managing Director DIN : 01077379 0. (1 ~ ~ ~ = m_.... ~ .... m=
Page 6
CAM LIN FINE SCIENCES LIMITED BALANCE SHEET AS AT SEPTEMBER 30, 2026 PARTJCUT.ARS ASSETS (I) Non-C urrent Assets (a) Property, Plant and Equipment (b) Cap ital work-in-progress (c) Righ t-Of-Use Assets (d) Investment Property (e) Goodwill (f) Intangible Assets (g) Financial Assets (i) Inves tme nts (i i) O ther financial assets (h) Deferred tax assets (net) (i) Income tax assets (j) Other non-current assets Total Non-current Assets (2) Current Asse ts (a) [nvcntorics (b) Financial assets . (i) lnves tments (ii) Trade receiva bles (iii) Cash and cash equ ivalen ts (iv) O ther bank balances (v) Loans (vi) Other fi nancial assets (c) O ther curre nt assets Total Curre nt Assets (d) Asse t held for sa le TOTAL ASSETS EQUffY AND LIABILITIES (1) EQU HY (a) Equity Sha re Capital (b) O ther Equity (c) >!on-Con trolling Interest Total Equity LIABILITIES (2) Non -current Liabiliti es (a) Financial Liabiliti es (i) Borrow ings (ii) Lease lictbilities (iii) Other fin.rncial liabilities (b) Prov is io ns (c) Defe rred tax liabili ties (net) (d) O ther non-c urrent liabilitic>s Tot al Non-Current Liabilities (3) Current Liabiliti es (a) Financia l Lidbilitics (i) Borrowings (ii) Lease liabilities (iii) Trade Payables (A) Total outstanding dues of micro en terprises and small en terpr ises; and (B) To tal ou tstand ing due s of creditors other than micro e nterprises and snw\I enter prises (iv) O ther financial liabiliti es (b) Ot her curren t liabilities (c) Prov is io ns (d) Current tax tiab1Jities (net) Total Current Liabiliti es Total Liabiliti es TOT AL EQU1TY AND LIABILITIES Place: Mumbai D.tte: Nove mber 03, 2026 (Rs in Million) STANDALONE CONSOl.IDATl'D 30.09.2026 31.03.2026 30.09.2026 ru naudil edl fAudiledl IUnaud iledl 4,790.94 4,876.15 114.92 226.97 271.70 263.64 102.92 115.97 2,398.45 2,170.90 51.67 59. 14 805.93 658.81 75.63 73.98 46.56 58.95 8,658.72 8,504.50 2,951.62 2,435.08 - 4,567.24 4,740.% 1.64 362.19 191.76 446.69 558.90 551.72 424.55 363.00 290.12 293.09 8,985.83 9,192.73 21.61 21.61 17,666.16 17,718.84 192.10 192.09 6,847.42 9,096.16 9,039.52 9,288.25 1,863.02 2,103.85 52.57 40.39 75.04 72.75 1,990.6..'l 2,217.00 2,501.52 2,6'13.% 51.15 60.79 1,079.00 834.17 2,657.26 2,322.33 256.20 253.17 41 .93 82.14 48.95 47.03 6,636.01 6,213.59 8,626.64 8,430.59 17,666.16 17,718.84 For Camlin Fine Sciences L1m1ted Ashish S. Dandekar Chairman & Managmg Director DIN: 01077379 5,711.22 237.02 615.64 2,334.11 265.18 310.10 187.n 1,001.59 188.91 49.85 10,901.39 5,805.36 - 3,371.68 494.97 191.76 340.70 1,549.17 11,753.64 21.61 22,676.64 192.10 9,526.63 (407.17) 9,313.56 2,653.63 418.66 3.78 75.04 39.05 1.47 3,191.63 3,639.99 169.54 1,079.27 4,381.55 592.15 222.14 85.68 1.13 10,171.45 13,363.08 22,676.64 31.03.2026 IAudiledl 5,692.11 328.52 558.78 2,334.11 288.74 302.62 183.54 873.84 25 1.62 60.24 10,874.12 5,037.42 3,730.16 1,085.55 446.69 578.29 1,465.19 12,343.30 21.61 23,239.03 192.09 10,216.71 (400.74) 10,008.07 3,026.06 344.02 3.22 72.75 39.08 1.62 3,486.74 3,654.75 176.10 836.08 4,215.85 617.76 151.88 9 1.04 0.76 9,744.22 13,230.96 23,239.03 Q Registered Office: Caml in Fine Sciences Limited, Floor 2 to 5, In G.S. Point , CST Road, Kalina , Santacruz (East), Mumbai 400 098 . CIN: L74100MH1993PLC075361 +91 22 6700 1000 -~ iii corporate@camlinfs.com www .camlinfs.com +91 22 2832 4404
Page 7
CAMLIN FINE SCIENCES LIMITED STA N DALONE STATEMENT OF CASH FLOWS FOR THE HALF YEAR ENDE D SEPTEMBER 30, 2026 Particul.i.rs Cas h Flow from O penting Activities (Loss) Before Tax Adjustuienl for: Dcpn!t'i<1liun dntl Amortisation ExpL'nsc Findnft ' Cosb Foreign Exch ..i. nj~l' Lo:;s / (G..i.m) (Unmih!:it'd) (Gain)/ Loss on sale of Prupl'rly, Planl & Equipmm t .md lnli\ngitik AsscL'I Allow.inct>/(Rt·vc rsul) ofCrC'tlil Luss ExpmS<:.•/(Rcwrsal) n•m1~ni.•wd in rcspc>t~ I of c>qmty-st>llled sharr-bascod paymPnL'i ProVL'iton for DrfinC'd Benefit Pldns Interest lncome lnlcrest tncome on othe r fin.mddl assl't~ Gudr-Jnll'l' Co mmission Prow.ion for inlt•n•st on MSME Nl't G.un .msm1~ on Finanri<il ASS('l'I mt'iiSun·d ..i.t r.m V,1Jw· ·nuou}',h Profit or Lo11s (~YI PL) Operating Profit before wo rkin g ca pital changes Adjust ml'nl for: ln1 rc\.1St'/(Dl't n•asl.') m Non Finani t.1! L1.1h11lltt'S ln1·n·.i..,t•/(D('t n«JM') in Fin.mlial L1uhiltl11·s (lncn«1..,1•)/D1't n·.ist• m Non Fm..1ntul A~!><'L'i (lm: rcas L')/DL'1:rca...,L' 1n F1nan...:1al Assl!ls Cts h ge nerat ed from operation s Taxt•s Paid (Nl'l) Net C.tSh Flow from Oper.iting .tctivities Cas h Flow from Investing Art-ivities Purrhasl' of Prnpl'rly, Plant&. Equipmt•nl urn..l lnli.ln)~ihh• Assets Sall' of Prop t•rly, Plant & Equipmt•nl and lntan1:ibl1· A'>St'L'i Arquisilion of ~uhsidiary Lo,m Lo Suhsidi<1ry <1nd ollwr~ Maturity of/ (lnvt•sLnwnt in) Fixed Dt•po..,1L lnlt.:n•..,t Rt't't•ivt•J Net Cash Flow used in Inv es tin g Ac tiv ities Cash flow from Fin.tncin g Aclivities Pron't•ds from lssul' of Equity Sh<lrt'!> umkr Ri,11.ht L..,sur ..1nd Emplnyet' Stock Option Pl.in Prrn:t't'tls from / (Rt'p aym t'nl of) Lnn)•, Term Borrowin.1•.s (Nl'l) Proceeds from / (Rt•p.iymt•nl of) Short Tt•rm Borrowm1:s (Nl' l) Paymml of k·a.sc• hahlliL1e~ lntc rL'sl Paid Net C•s h Flow from/ (used in) Financing Activities Net Incre ase in Cas h & Cash Equivalents Cas h & Cas h Equivalents at the beginnin g of th e year Cas h & Cas h Eciuivalents al th e e nd of pe riod No te: For half year ended Sep tember 30,2026 (Unaudited ) (498.48) 273.I>! 28X.69 (16.+l) 2.-!6 30.59 1-l.95 5.81 (24.61) (!UG) (U7) 11.51 107.30 (41.X2) 662.H9 (512.52) 110.01 325.88 11 .67l 324.21 (4!J.6Y) (0.!)2) h7.hl) (1.88) (24.25) 2.8'\ 3.60 O.HJ (33n.10) (37.97) (41.90) 1272.49 1688.36 (360.55) 362.19 1.64 Rs (inMillion s) For hal f year ended September 30,2025 (Un.i.udited) (201.87) 268.77 'l!XJ.71 (6".2 1) U.93 (0.76) HD7 (37.39) (0.37) (U7) 12.26 flX.117) 275.02 (21.!IX) 5915 225.64 '107.'8\ 431.25 (1.171 430.08 lTIX.-42) (:J.l 30) (13 18) 165.48 8.82 6.20 4.51 221.71 (Mn.67) (37.73) 1219.961 1676.121 (239.84) 360.66 120.82 (d) 11w <lhnvt• C.l~h Flnw SWtt•nwnt h.i~ hr't'll prt'p.!r('t.l untl1•r lht• Klml in't·t Mt·lhod J'i <>t'L nut in tlw lndi,m J\11 nunling Slund.ird (Ind J\S 7) - St..i1t•rn1·nl ofCJsh Flow~. b COi.Sh .ind Cas h E uivdl cnt s fOm rises of: P.i.rticul.trs Bd!dnt<..'S w1lh B<.rnks m Curren t Acrnu nL'i Bank Jepo:.iLo.; with ori1:inJ.I mJ.tunly of kss Uldn thrL't.' months C.1sh on I land C1s h and cash c uival cn ts in Standalone Balance Sheet Pl.in •: Mumlxu 0,1L1•: Nuvl'mht·r 01, 2026 For half year ended Sep tember 30,2026 (Un.audited 0.5<\ 1.64 For half year ended September 30,2025 (U1uudit"d) 5.71 1U.7'.\ 0.32 120.82 Fm Cc1mhn Fmt' Sc 11·m1.., Llm1h'li Ashish S. Dandekar Ch..11rn1.:in k M.m..1gmg D1rt•t tor DIN' 1Jl!l7737Y Q Registered Office: Camlin Fine Sciences Limited, Floor 2 to 5, In G.S. Point , CST Road, Kalina, Santac ruz (East), Mumbai 400 098 . CIN: L74100MH1993PLC075361 -·~ 'i +91 22 6700 1000 m +91 22 2832 4404 iilii corporate@camlinfs.com www.camlinfs.com
Page 8
Q CAMLIN FINE SCIENCES LIMITED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE HALF YEAR ENDED SEPTEMBER 30, 2026 (Rs.in Million) For the half yea r ended For the half yea r ended Particulars Se ptember 30, 2026 Septe mber 30, 2025 (Unaudit ed) (Unaudited) Cash Flow from Operating Activities Profit I (Loss) Before Tax Continuing operations (671.47) 8.51 Discontinued operations (34.45) (205.80) Adjustment for: Depreciation and amm1isation expense 390.75 357.48 Finance costs (Includi ng ofMSME Interest ) 381.92 343.56 Foreign exchange loss I (gai n) (unrealised ) 37.85 (16624) Loss on salc1discard of Propc11y, Plant & Equipment 1A6 0.93 Allowance for Doubtflil debts and advances (Net) 35.64 (0.76) Shortfall arising from the scltlcmcnt of Insurance claim 94.06 Net Expenses recognised in respect of equity settled share based payments 22.35 Provision for defined benefit plans and compensated absences 4.44 34.27 Interest income (6.96) (20.52) Hyperinflationary effec t on Consolidat ed Statement of Profit and Loss (0.03) 16.06 Share of (profit)/ loss of associate of step down subsidiary (17.58) (533) Net gain arising on Financial Liabilities measured at Fair Value Through Profit or Loss (FVTPL) - (I 8.07) Operatin g Profit before working capital changes 238.98 344.07 Adjustment for: lncrcase/(Decrcase) in Non Financial Liabilities (7.10) 12.96 lncrease /(Decrease) in Financial Liabilities 530.60 352.85 (lncreasc)/Dccrcasc m Non Financial Assets 6.16 ( l 7.57) (Increase )/Decrease in Financial Assets (332.58) 165.06 Cas h gener ated from operations 436.06 857.37 Taxes Paid (Net) (20.38) (185 99) Net Cas h Flow from I (used in) Operating acti vities 415.68 671.39 Cash Flow from Investing Activities Purchase of Property , Plant & Equi pment and Intang ible Assets (237.60) (296.56) Sale/ (Purchase) of non-cuITent investment s - (34 50) Dividend received from associate company 9.80 Acquisition of additional interest in subsidiary from non-controlling interests (220.15) Maturity of I (Investment in) Fixed Deposit ('.'Jct) 26 1.89 159 41 I merest Rccci vcd 6.96 1146 Net Cas h Flows from I (used in) Investing Activities (179.10) (160.19) Cash Flow from Financing Activities Proceeds from Issue of Equity Shares under Employee Stock Option Scheme I Plan 0.10 4.53 Proceeds from I (Repayme nt of) Long Tenn BoITowings (Net) (506.12) 537.81 Proceeds from I (Repayme nt ot) Short Term Borrowings (Net) 80.14 (854.36) Paymcnl of lease liabilities (83.17) (77.99) Interest Paid (318.1 1) (287.53) Net Cash Flow from I (used in) Financin g Activities (827. 16) (677.5 4) Net Increase/ (Decrease) in Cash & Cas h Equivalents (590.58) (166.34) Cas h & Cash Equivalents at the beginning of the period 1,085.55 1,040.7 1 Cash & Cas h Equivalents at the end of the period 494.97 874.36 Notes: (a) The above Consolidated Statement of Cash Flows has been prepared under the "Indirect Method" as set out in the lndran Accounting Standard (Ind AS 7) - Statement of Cash Flows . (b) Cash and Cash Equiva lents comprises of· Pa rticulars Balances with banks in cunent accounts Bank deposits with original maturity of less than three months Cash on hand Cash and cash eQttivalents in Co nsolidated Balance Sheet Place· Mumbai Date: November 03, 2026 - As at September 30, 2026 493.66 1.31 494.97 (Rs.in Million) As at March 31 , 2025 758.62 114 74 1.00 874.36 FOR CAMLIN FINE SCIENCES LIMITED !\shrsh S Dandekar DIN- 01077379 f"J;i '- +91 22 6700 1000 !!fill +91 22 2832 4404 i:ii corporate@camlinfs.com 0 www.camlinfs.com
Page 9
ANNEXURE-1 CAMLIN f!NE SCIENCES LIMITED UNAUDITED CONSOLIDATED SEGMENT INFORMATION FOR '!TIE SIX MONTHS ENDED SEPTEMBER 30, 2026 {Rs. in Million) QUARTER ENDED PERIOD ENDED YEAR ENDED PARTICULARS 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudi ted) (Unaudited) (Unaudited) (Unaudited) Segment Revenue Specialty Ingredients 4,078.80 4,013.17 3,231.33 8,091.97 6,167.41 13,116.23 Arom.i. 471.55 774.07 798.54 1,245.62 1,365.41 2,390.86 Perfor1nance Chem1cdls & Others 1,856.82 1,748.90 1,572.51 3,605.72 3,084.15 5,814.88 Gross Segment Revenue 6,407.17 6,536.14 5,602.38 12,943.31 10,616.97 21,321.97 Less: Inter Segment R('venuc 1,492.52 1.337.35 1,099.72 2,829.87 2,037 11 4,088.89 Revenue from operations 4,914.65 5,198.79 4,502.65 10,113.44 8,579.86 17,233.08 Segment Results Specialty Ingredi ents 327.91 254.66 358.87 582.57 658.73 1,276.27 Aroma (108.90) (33.81) 87.00 (142.70) 66.58 (240.23) Performance Chemicals & Others (196.69) (44.41) (89.59) (241.11) (166.11) 32.75 Scg1ncnt results before exceptional items 22.33 176.44 356.28 198.76 559.21 1,068.79 Less: txccptional Items Spt..-•u,1lty Ingrl'd1cnls 19.26 108.80 128.06 76.34 Aroma - Performdnce Ch<>micals & Others Undllocdtcd - Segment results after Exceptional Items 3.07 67.64 356.28 70.70 559.21 992.45 Less/ (Add): (i) Finance costs 205.92 140.05 178.48 345.97 327.04 729.40 (ii) Depreciation & Amortisation 199.19 191.56 176.55 390.75 337.88 709.19 (iii) Other income (excluding foreign exchange gain) (13.63) (13.40) (13.94) (27.03) (18.77) (287.92) (iv) Foreign exchonge loss/ (gain) (35.93) 83.69 (28.68) 47.76 (90.12) (v) Exc(>ptio1MI items (unallocated) (0 00) 2.30 2.30 178.26 (vi) ShMc o( pro(it /(loss) of associdtc 3.61 13 97 (3.58) 17.58 5.33 16.62 Profit/ (I.oss) before tax (348.87) (322.59) 40.29 (671.47) 8.51 (319.86) ASAT PARTICULARS 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) Segment ASSl'ls Specialty Ingredie nts 11,252.6-1 12.034.58 7,875.61 11 ,252.64 7,875.61 11,487.74 Arom<l 3,681 .70 3,863.87 3,592.17 3,681.70 3,592.17 3,980.19 Pcdorm<1.nC(' Chcmic.,ls & Others 6,42"1.72 6,142.10 7,737.12 b,421.72 7,737.12 6,493.61 Un,lll ocatcd 1,320.58 1,258.95 1;164.35 1,320.58 1,164.35 1,277.49 TOtill 22,676.64 23,299.50 20,369.25 22,676.64 20~%9.25 23,239.03 Segment Liabilities Specialty lngrcd1cnts 6,941.39 7,362.00 o,940.92 6,941.39 :>,940.92 6,886.61 Aromd 2,187.50 2,262.48 2,100.85 2,187.50 2,100.85 2,431.().J Pedormdnce Chemicals & Others 4,118.92 3,708.61 3,601.22 4,118.92 3,601.22 3,800.73 U1Mllocated 9,428.83 9,966.41 8,726.26 9,428.83 8,726.26 10,120.65 Total 22,676.64 23,299.50 20,369.25 22,676.64 20,369.25 23,239.03 Notes: The M.rn.tging Directors rcv i('w and evaluate thr Group's oper"ting pcrform.tnce to make dC''Cls1ons "bout resources to be alloc.ttcd lo vMious busmesses .tnd have been identified .i.s Chief Operat ing Dedsion Makers (CODM). Based on the information provided to the CODM, it has been determined that the Group has three business reporting segme nts. The business of each segment comprises of: I. Speci.i.lty Ingredients: This is the m.i.in business ared of the Group's operation and include~ m.i.rkcting of conven hondl antiox1d..,11t clwm1cdls, .rnd m.:inuf~clunng and markeling of blends, emulsifier s, functional ingred ients, starches , additives, etc. rntering to industries engdged m Food, Animd l ~utrillon & Fc<>d, Pct Food , 810 diesels, Oil & F.i.t, Dairy, Bakery. Confccho ncry, Mc·at, etc. All these products include inorgamc , natural as well as clean label 2. Aroma: This seg ment of the Group's operation includes manufacturing and mdrketing of dromalic products such as Yleth) IV an1llm, Ethyl Vamllm .rnd related derivatives 3. Perform.i.nce Chcmicd ls & Others: This segment will include tlu" manufacturing ant.I mdrketmg of chcm1cdl such as D1phenols, Phenolic Compounds, Performance & lndustn"I chemicals and o ther downstream & deri vatives. ThJS segment wLll also include other mmor residuary busmesses Accordingly, segment informdtion is presented in respect of the dbove identified bu-.incss segments, wherein the pcrform.i.nce is eva\udtcd bdsed on opcr.i.tion.i.I EBnnA (without foreign exchange gdin / loss). All inter-segment transactions are conducted on normal commercial terms not more favourable th.rn those generally available to externa l parhes and m line with the arm's length principlt.~. Q Registered Office: ~ +91 22 6700 1000 -~ + S. Point. CST Road , Kalina, Santacru i1lii corporate@camlinfs.com www.camlinfs.com
Page 10
KALYANIWAL LA & M I STRYLLP CHA R TE R E D ACCO U NTANTS REVIEW REPORT To The Board of Directors Camlin Fine Scie nces Limited I) We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of Camlin Fine Sciences Limite d ("the Company") for the quarter and half year ended September 30, 2026, together with the Standalone Unaudited Balance Sheet, Statement of Standalone Unaudited Cash Flows and notes thereon , ("the Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the Listing Regulations"), duly initialled by us for identification. This Statement, which is the responsibility of the Company's Management, has been reviewed by the Audit Committee and approved by the Board of Directors , at their respective meetings held on November 3, 2026, and has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting ' ("Ind AS 34") prescribed under Section 133 of the Companies Act, 2013, ("the Act") read with relevant Rules issued thereunder, as applicable and other accounting principles generally accepted in India . Our responsibility is to issue a report on the Statement based on our review. 2) We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ''Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants oflndia. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3) Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Kalyaniwalla & Mistry LLP Chartered Accountants Firm Registration No.: 104607W /W100166 ~ Partner Membership No.: 047576 UDIN: 2.o <:>'11 Sib \.>'f \<..\I I>-(,.:. c.,o\l2.. November 03, 2026, Mumbai LLP IN: A AH · 3437 REGISTERED OFFIC E : ES P L A N A DE HO U SE, 29, HA ZARIM A L SOMANI MARG , FORT, MUMBAI 400 001 TEL.: (Q1l (22l 61~8 6200. 61~8 7200 FAX: (q1\ l22l 61~8 62n
Page 11
KALYANIWALLA & MISTRYLLP CHARTERED ACCO UNTA NTS REVIEW REPORT To The Board of Directors Camlin Fine Sciences Limited I) We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of Camlin Fine Sciences Limited ("the Parent"), and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group") and its share of net profit after tax and total comprehensive income of an associate of a step down subsidiary (refer paragraph 3 below) for the quarter and half year ended September 30, 2026 together with the Consolidated Unaudited Balance Sheet, Statements of Consolidated Unaudited Cash Flows and notes thereon ("the Statement") attached herewith, being submitted by the Parent pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, ("the Listing Regulations"), duly initialled by us for identification. This Statement, which is the responsibility of the Parent's Management has been reviewed by the Parent's Audit Committee and approved by Parent's Board of Directors, at their respective meetings held on November 3, 2026, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, ("the Act"), read with relevant Rules issued thereunder, as applicable and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 2) We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants oflndia. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33 (8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. 3) The Statement includes the results of the following subsidiaries I step down subsidiaries I associate: Sr. No. Name of the Entity Relationshio Incorporated In India i. Chemolutions Chemicals Ltd. Subsidiarv ii. Alga!R Nutra Pharms Private Limited Subsidiarv Incoroorated Outside India iii. CFS North America LLC Whollv owned subsidiarv iv. CFS Do Brasil Industria, Comercio, Importayao Wholly owned subsidiary e Exoortacao De Aditivos Alimentfcios LTDA v. Solentus North America Inc (Struck off w.e.f. Wholly owned subsidiary May 12, 2026) LLP IN : AAH · 3437 REGISTERED OFFICE : ESPLANADE HOUSE, 29, HAZARIMAL SOMANI MARG , FORT , MUMBAI 400 001 TEL.: (q1) (22) 61<;8 6200, 6158 7200 FAX: (91) (22) 6158 6275
Page 12
K A LY AN I WA L LA & M IS TR Y L LP Sr. No. Name of the Entity Relationship vi. Dresen Quimica S.A.P.I de C.V. Wholly owned subsidiary Vil. Industrias Petrotec De Mexico S.A. de C.V. Step down subsidiary viii. Nuvel, S.A.C. Step down subsidiary ix. Britec , S.A. Step down subsidiary x. !novel, S.A.S Step down subsidiarv XI. Grine!, S.R.L Step down subsidiary xii. CFS Wanglong Flavors (Ningbo) Co. Ltd. Subsidiary ... CFS Argentina S.A. Step down subsidiary XIII. XIV. CFS Chile De SPA Step down subsidiary xv. CFS PP (M) SDN. BHD Subsidiary XVI. Vitafor Invest NV, Belgium Step down subsidiary xvii. Yitafor NV, Step down subsidiary xviii. Addi-Tech NV Step down subsidiary XIX. Vitafor China Ltd. Step down subsidiary xx. Vial SARL Associate of a step-down subsidiary ofVitafor NV. XX!. Vinpai S. A. Subsidiary XX!!. Based Algae & Plants, France Step down subsidiary 4) Based on our review conducted and procedures performed as stated in paragraph 2 above , and based on the consideration of the review reports of the other auditors referred to in paragraph 5(A) below, nothing has come to our attention that causes us to believe that the accompanying Statement , prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5) Other Matters : A. We did not review the interim financial results of 13 subsidiaries incorporated outside India and 2 subsidiaries in India included in the Statement, whose interim financial results reflect Group's share of total assets (before consolidation adjustments) of Rs. 10,674.03 million as at September 30, 2026 and Group 's Share of total revenues (before consolidation adjustments) of Rs. 3, 186. 76 million and Rs. 6,894.69 million for quarter and for half year ended, respectively , Group's share of total net loss after tax (before consolidation adjustments) of Rs. 47.55 million and Rs 229.74 million for quarter and for half year ended, respectively, and total comprehensive income (before consolidation adjustments) loss of Rs. I 08.96 million and Rs. 205.26 million for quarter and for half year ended, respectively, and cash flow (net outflow) (before consolidation adjustments) of Rs. 22 l. 75 million for the half year ended September 30, 2026. These interim financial results of the subsidiaries as mentioned in this paragraph have been reviewed by other auditors whose reports have been furnished to us and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries , is based solely on the reports of the other auditors and the procedures performed by us as stated in paragraph 2 above. fn respect of the subsidiaries located outside India, the interim financial results and other financial information have been prepared in accordance with accounting principles generally accepted in their respective countries and which have been reviewed by other auditors under generally accepted auditing standards applicable in their respective countries. The Parent's Management has converted the interim financial results of these subsidiaries located outside India from accounting principles generally accepted in their respective countries to accounting principles generally accepted in India (Indian
Page 13
KALYANIWALLA & MISTRY LLP Accounting Standards "Ind AS"). We have reviewed the conversion adjustments made by the Parent's Management. B. The Statement includes interim financial results of 6 subsidiaries incorporated outside India which have not been reviewed, whose interim financial results reflect Group's share of total assets (before consolidation adjustments) of Rs. 1,366.72 million as at September 30, 2026 and Group's Share of total revenues (before consolidation adjustments) of Rs. 19.19 million and Rs. 42.01 million for quarter and for half year ended, respectively, Group's share of total net loss after tax (before consolidation adjustments) of Rs. 40.33 million and Rs. 89.21 million for quarter and for half year ended, respectively, and total comprehensive income (before consolidation adjustments) loss of Rs. 127.76 million and Rs 156.57 million for quarter and for half year ended, respectively and cash flow (net outflow) (before consolidation adjustments) of Rs. 126.91 million for the half year ended September 30, 2026. The Statement also includes the Group's share ofnet profit after tax (before consolidation adjustments) and total comprehensive income (before consolidation adjustments) of Rs. 3.61 million and Rs. 17.58 million for quarter and for half year ended, respectively, as considered in the consolidated unaudited financial results, in respect of an associate of a step-down subsidiary, located outside India, which have not been reviewed. These interim financial resu lts have been furnished to us by the Parent's Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries and an associate of a step-down subsidiary, is based solely on such interim financial results certified by the Management. According to the information and explanations given to us by the Management, these interim financial results are not material to the Group. Our conc lusion on the Statement is not modified in respect of the above matters. For Kalyaniwalla & Mistry LLP Chartered Accountants Fi egistration No.: 104607W/Wl00166 Partner Membership No.: 047576 o. b 3 UDIN: 'l-,E,o 'f7~=t.G f)F OSVK 'i>v November 03, 2026, Mumbai
Page 14
4 <> n n ::o + - CJ CD ~ :z 3 If!. N r= Ill N -....i ::i iD (j) .p. Tl ... ---' - · CD -....J 0 ::i a. 0 0 <O 0 3: (/) 0 ~ IQ. :ii 0 ~ ro n 0 l.O ::i CD 0 l.O n .. VJ <O \J (f) rr n-· o3 11 -....J;::;: Ul <O VJ D.. O"l • + ~ Tl ~ 0 0 N ..... N N N rt ro 0 (.N Y1 N ~ S' ~ 0 0 ~ yi \J 0 ::i a .:" n (/) -I n ;:o 0 ..... 0 "O CJ 0 D.. ..... . CJ r;: rt <O CJ @ ::i () CJ CJ . 3 (/) CJ ::i ::i ...., rt Ul CJ 0 () ..... 0 c 3 N "" m CJ Ul rt (] ::--' 3: c 3 :E O" :E CJ :E .p. 0 0 CJ 0 3 0 l.O ::i ...., ~ Ul 0 0 3 S TATE\i:E~T OF U:'\AU OITED FI'.\'AXCIAL RFSUL TS FO R QUARTER ENDED SEPTEMBE R 30, 2026 (Rs.i n Mill ion, e:xcep t per s hare da ta) STANDALONE CONSO LIDATED QUARTER ENDED HALF YEAR ENDED YEAR I '.'\OED QUARTER ENDED HAl.F YEAR EN DED YEAR E'.'\DED :-.ro. I PARTI CULA RS 30.09.2026 30.06.2026 JCl.09.2025 30.09.2026 Jo.09.2025 31.03.2026 30.09.2026 30.06.2026 30.09 .2025 30.09.20 26 30.09.2025 31.03.2026 (U n audi ted} (Unaudited) (U n au di ted ) (Unaud ited) (Unau dited) (Audited) (linaud itcd ) (Unaudited) (Un au dited) {Un au d ited) (Unaudit ed ) (Audi ted) Tot<1l ln(_Onw from Oper<1lio11s J 2,+.1583 2,22.t.86 2,+i0.12 1,670.68 .J,35--1.80 fl,.\79 lK 1,91465 5,198.79 -i,50265 10,113.+-I 8,579.86 17,H'\08 Nd Prof1l / (Loss) for lh.t! period from co11tinumg (3117 1) (186.72) (1810) (198 18) (201.86) cm~ 2'l (329.61) (211.49) 10 ,0 ('»1.11) 8.51 (05 26) oper<11Lons (Ix-fore ldx .ind cxt.cplional items) Net Profit / (Loss) for the period before tr1x from (3117-1) (186.72) (\8.10) (198 18) (20186) (51092) (318.87) (32259) 1029 (67U7) 8.51 (.\19.SO) conlinmnt'. O\X'Tdlions (.1fter exceptional items) Tol,11 Net Profit / (Loss) for the pt•riod dfter t.i' (.1fl.-.r (20009) (12312) (36.39) (323.2•) (W.19) (329 66) (29700) (336.22) (ll9.50) (6JJ N) (256.31) 2'5 I' CXCfTtlO!ldl 1\t•ms) /\'ct Profit / Loss for the period .. iftcr t.1x nnd non (278.5-1) (317.06) (1 llRl) (595.62) (W.'5) 27627 controllmg intC'rcsto; (after exception.ii it<'ms) ' ITol<I Con'I"''""'""" hKome foe llw 1>e>nod (ls.t58) (8628) (78 92) (270.87) (18348) (.,7662) (ll6.65) (16362) (159.211) (510.27) (1-16.81) 26'-JW 7 Eqmty Sh<1r(' C.1p1t.1I 19210 19210 187.98 192.10 187.98 19209 19210 19210 18798 192.10 18798 1921.)t) 8 Otht'r Ecimtv 8,81712 s,25sn 9,096 16 9,528.63 8,707.75 10,21671 EMnmgs J><'f ~h<lrl' (of Rt' I/ Ct!Ch) (not .rn:n:.thSl'd) B;isic Rs (1().1) (O.IH) (0.19) (1.61!) (0.76) (I 71) (1.45) (1.65) (077) (3.10) (1.30) 1.- 16 Dilull'<i Rs (10.1) (O.IH) (019) (1.68) (0.76) (I 71) (1.45) (1.65) (077) (3.10) (1.30) 1.:.1 L\!"otc The t1lx1VL' rnform.1llon l'i d!l t•xtra(_t or ilw dC'tnilC'd lorm.1\ o( unc1uditl'd rt'su!ts for the qunrlt"'r endl'd Sc-ptt•ni!1'..·r "\O, 2026 filL·d v.'ilh the Stoc"- ExdM!l/\''" unJvr RL•gulntion 33 of the SEBI (Listing Obhe,1tmns .tml IJ1'i<Josurl' R(-qu1rcments) Rcgul.illon<., 2015 Tiii' foll form.it of th1• 1:n.r1udit('d results for the 1.1u.irlt•rScp1t•mh1.•r 10, 2026 ttr(' .iv.1il<1blc on the Compdll)''s wdl'i1ll' .11 hlVW • .im[infs.com .ind lh(• Slock. Exch.1111\•' •11•b-.1h .. s 1.c. www bscindia.com dnd \1•ww nS1•11u!1.i n1111 For C.unlin Fin<' Sciences Lim ited Place: Mumbd1 D;itc: Nowmbt:•rO-'. 2026 0. (l SJ ~ ~ = <D ii-- ~ --m=
Page 15
Annexure 2 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. No. Particulars Details I. Type of securities proposed to be issued (viz. equity shares, convertibles, etc.) Equity Shares II. Type of issuance (further public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) Rights Issue III. Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately) not exceeding ₹ 250 crores IV. In case of preferential issue the listed entity shall disclose the following additional details to the stock exchange(s) Not Applicable V. In case of bonus issue the listed entity shall disclose the following additional details to the stock exchange(s) Not Applicable VI. In case of issuance of depository receipts (ADR/GDR) or FCCB the listed entity shall disclose following additional details to the stock exchange(s) Not Applicable VII In case of issuance of debt securities or other non - convertible securities the listed entity shall disclose following additional details to the stock exchange(s) Not Applicable VIII. Any cancellation or termination of proposal for issuance of securities including reasons thereof Not Applicable